Sign In
Buy AXGN
$40.63
+1.17 (+2.97%)
At Close: Jun 03, 2026
Edited Transcript of AXGN earnings conference call or presentation 24-Feb-20 9:30pm GMT
12:05pm, Friday, 06'th Mar 2020
Q4 2019 AxoGen Inc Earnings Call
Visiongain Launches Report Examining the Potential in the $118bn Translational Regenerative Medicine Market
10:00am, Friday, 06'th Mar 2020
The Global Translational Regenerative Medicine market is estimated to grow at a CAGR of 24% in the first half of the forecast period. Stem cell therapies accounted for the majority of the revenue in t
Edited Transcript of AXGN earnings conference call or presentation 24-Feb-20 9:30pm GMT
07:48pm, Wednesday, 04'th Mar 2020
Q4 2019 AxoGen Inc Earnings Call
Axogen, Inc. to Participate at Upcoming Investor Conferences
12:00pm, Monday, 02'nd Mar 2020
Axogen, Inc. (AXGN), a global leader in developing and marketing innovative surgical solutions for damage or discontinuity to peripheral nerves, today announced that members of its management team wil
Axogen, Inc. to Participate at Upcoming Investor Conferences
12:00pm, Monday, 02'nd Mar 2020
ALACHUA, Fla., March 02, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions...
AxoGen, Inc (NASDAQ:AXGN) Sees Large Decline in Short Interest
09:44am, Monday, 02'nd Mar 2020
AxoGen, Inc (NASDAQ:AXGN) saw a large drop in short interest in February. As of February 14th, there was short interest totalling 1,500,000 shares, a drop of 9.6% from the January 30th total of 1,660,
AxoGen, Inc (NASDAQ:AXGN) Expected to Earn FY2020 Earnings of ($0.69) Per Share
08:56am, Monday, 02'nd Mar 2020
AxoGen, Inc (NASDAQ:AXGN) – Cantor Fitzgerald decreased their FY2020 earnings per share (EPS) estimates for shares of AxoGen in a research note issued to investors on Wednesday, February 26th. Canto
Axogen, Inc. to Participate at Upcoming Investor Conferences
12:00am, Monday, 02'nd Mar 2020M&T Bank Corp Buys 2,883 Shares of AxoGen, Inc (NASDAQ:AXGN)
12:50pm, Sunday, 01'st Mar 2020
M&T Bank Corp increased its stake in shares of AxoGen, Inc (NASDAQ:AXGN) by 21.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 16,123 shares
Q2 2020 Earnings Forecast for AxoGen, Inc (NASDAQ:AXGN) Issued By Jefferies Financial Group
08:26am, Saturday, 29'th Feb 2020
AxoGen, Inc (NASDAQ:AXGN) – Analysts at Jefferies Financial Group lowered their Q2 2020 earnings per share (EPS) estimates for shares of AxoGen in a note issued to investors on Tuesday, February 25t
AxoGen, Inc Expected to Post Q1 2020 Earnings of ($0.27) Per Share (NASDAQ:AXGN)
11:42am, Friday, 28'th Feb 2020
AxoGen, Inc (NASDAQ:AXGN) – Equities researchers at Svb Leerink issued their Q1 2020 earnings per share estimates for shares of AxoGen in a research note issued to investors on Tuesday, February 25t
AxoGen, Inc. Just Reported, And Analysts Assigned A US$22.17 Price Target
12:20pm, Thursday, 27'th Feb 2020
It's been a sad week for AxoGen, Inc. (NASDAQ:AXGN), who've watched their investment drop 13% to US$12.99 in the week...
Organogenesis: Undervalued And Promising Investment Opportunity For 2020
09:37am, Thursday, 27'th Feb 2020
Puraply is a key growth driver of Organogenesis’ advanced wound care business. There are multiple short-term, mid-term, and long-term growth catalysts for the c
Analysts Have Been Trimming Their AxoGen, Inc. Price Target After Its Latest Report
10:53am, Wednesday, 26'th Feb 2020
It's been a mediocre week for AxoGen, Inc. (NASDAQ:AXGN) shareholders, with the stock dropping 18% to US$12.12 in the...
